Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
This study is currently recruiting participants.
Verified December 2011 by University of Pittsburgh
Sponsor:
University of Pittsburgh
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01488318
First received: November 30, 2011
Last updated: December 6, 2011
Last verified: December 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | May 2014 |
| Estimated Primary Completion Date: | October 2013 (Final data collection date for primary outcome measure) |